Teva withdraws Shield patent oppositions
19-10-2020
European Commission calls out Teva over anti-competitive practice
18-07-2017
EIP hires Teva litigator
07-01-2014
ESB Professional / shutterstock.com
Drug company Teva has lost an appeal over its bid to trademark two word signs, after the tenth chamber of the EU General Court ruled in favour of the European Union IP Office (EUIPO) yesterday, July 8.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Teva, EU General Court, EUIPO, trademark, migraine, goods, slogan, ‘French, public, company
